Craig Doig

Craig is an Associate Professor of Metabolic Health. He is interested in the basic mechanistic biology of both cells and tissue systems, working to apply this understanding towards treatment strategies targeting human disease. The laboratory are focussed upon the mechanisms and metabolic roles of NAD+ consuming enzymes and interactions with steroid hormone signalling.

Prior to his career in academia, Craig was an analytical scientist working with 3M Health Care, Astra-Zeneca, Merck and Sanofi-Aventis. For his doctoral training Craig was located at Roswell Park Cancer Institute, Buffalo, New York USA. Here he studied mechanisms of transcriptional control in cancer, employing epigenetic techniques and DNA methylation analysis. As a postdoctoral researcher, Craig trained within the fields of endocrinology and molecular metabolism at the Centre for Endocrinology Diabetes & Metabolism and the Institute of Metabolism & Systems Research at University of Birmingham. His work revealing the roles of steroid hormone biochemistry and its impacts upon tissues including brown adipose and skeletal muscle. These projects have helped define current understanding of endocrinology, metabolism and mitochondrial function.

Craig is strongly interested in the regulation of physiology, endocrinology, epigenetic signalling and how they impact metabolic pathways in health and disease.